UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

Under the Securities Exchange Act of 1934

For the month of ~~December~~February, ~~2025~~2026

Commission File Number 001-40772

Cellebrite DI Ltd.

(Translation of registrant’s name into English)

94 Shlomo Shmelzer Road

Petah Tikva 4970602, Israel

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

EXPLANATORY NOTE

~~Completion~~On February 11, 2026, Cellebrite DI Ltd. (the “Registrant” or “Cellebrite”) issued a press release titled “Cellebrite Announces Record Fourth-Quarter and Full-Year 2025 Results.” A copy of ~~Corellium~~this ~~Acquisition~~press release is furnished as Exhibit 99.1 herewith.

OnThe ~~December~~GAAP 1,financial ~~2025,~~statements ~~Cellebrite~~tables ~~DI Ltd.~~contained (in the ~~“Registrant”~~press ~~or “Cellebrite”) completed its previously announced acquisition of Corellium, Inc. (“Corellium”),~~release ~~pursuant~~attached to ~~the~~this ~~Agreement~~report ~~and~~on ~~Plan~~Form of6-K ~~Merger,~~are ~~dated~~incorporated asby ofreference ~~June~~into ~~4, 2025 (~~the ~~“Merger~~Registrant’s ~~Agreement”),~~registration bystatements ~~and~~on ~~among~~Form ~~Cellebrite, Corellium,~~S-8 ~~Cellebrite Inc~~(File Nos., a333-260878 ~~Delaware corporation~~ and ~~wholly~~333-278130) ~~owned~~filed ~~subsidiary~~with ~~of Cellebrite (~~the ~~“Buyer”), Valient Merger Subsidiary, Inc~~U.,S. aSecurities ~~Delaware corporation~~ and ~~wholly~~Exchange ~~owned~~Commission ~~subsidiary of Buyer~~ (the “~~Merger Sub~~SEC”), ~~and~~on ~~Shareholder~~November ~~Representative Services LLC~~8, a2021 ~~Colorado limited liability company solely in its capacity as the representative of Corellium securityholders. Pursuant~~and toMarch ~~the~~21, ~~Merger~~2024, ~~Agreement~~respectively, ~~Merger Sub merged with~~ and ~~into~~Form ~~Corellium~~F-3 (~~the~~File ~~“Merger”~~No. 333-259826), filed with ~~Corellium surviving~~ the ~~Merger~~SEC ~~as an~~on ~~indirect~~September ~~wholly~~13, ~~owned subsidiary of Cellebrite~~2022.

On December 2, 2025, Cellebrite issued a press release (the “Press Release”) titled “Cellebrite Completes Acquisition of Corellium, Extending the Industry’s Most Advanced AI-Powered Digital Investigation Platform”. A copy of the Press Release is furnished herewith as Exhibit 99.1.

The contents of this Report on Form 6-K and only the sixth paragraph of the Press Release are incorporated by reference into the Registrant’s registration statements on Form S-8 (File Nos. 333-260878 and 333-278130) filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 8, 2021 and March 21, 2024, respectively, and Form F-3 (File No. 333-259826) filed with the SEC on September 13, 2022, to be a part thereof from the date on which this Report on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

EXHIBIT INDEX

Exhibit		Description
99.1		Press release titled “Cellebrite ~~Completes~~Announces ~~Acquisition~~Record ofFourth-Quarter ~~Corellium,~~and ~~Extending the Industry’s Most Advanced AI~~Full-~~Powered~~Year ~~Digital~~2025 ~~Investigation Platform~~Results” (furnished herewith).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Cellebrite DI Ltd.
Date: December 2, 2025	By:	/s/ Holly Windham
Date: February 11, 2026	By:	/s/ David Barter
		Holly Windham
		David Barter
		General Counsel
		Chief Financial Officer

Filing Compare · Cellebrite DI Ltd.